Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma

Table 3

Overall survival (OS) rate of stages I and II melanoma patients according to MIA serum concentration.

MIA; ng/mL	Number of patients	Number of deaths	1-year OS	2-year OS	3-year OS	4-year OS	Mean OS (95% CI)	Median OS (95% CI)
≥9.4	24	14	87.5%	62.5%	43.8%	38.9%	2.9 years; [2.3–3.6]	2.9 years; [1.7–4.0]
<9.4	60	3	98.3%	96.2%	93.3%	93.3%	4.4 years; [4.1–4.6]	—